Literature DB >> 21054959

[Prevalence of metabolic syndrome in psoriasis inpatients in Peking Union Medical College Hospital].

Feng Li1, Hong-zhong Jin, Bao-xi Wang.   

Abstract

OBJECTIVE: To explore the prevalence of metabolic syndrome in psoriasis inpatients in Peking Union Medical Hospital.
METHODS: We retrospectively reviewed the records of the psoriasis patients admitted in the dermatological ward of Peking Union Medical College Hospital from January 1st, 2003, to December 31st, 2008, and the height, weight, blood pressure, fasting glucose, triglyceride, and high-density lipoprotein levels were recorded.
RESULTS: The prevalence of metabolic syndrome of the psoriasis inpatients of Peking Union Medical College Hospital was 38.1%, with that of the male patients (43.1%) significantly higher than the female (25.0%, P0.05).
CONCLUSIONS: Prevalence of metabolic syndrome in psoriasis patients is higher than healthy adults. Screening and patient education are important for these patients in clinical practice.

Entities:  

Mesh:

Year:  2010        PMID: 21054959     DOI: 10.3881/j.issn.1000-503X.2010.05.024

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  3 in total

1.  Metabolic syndrome in patients with psoriatic disease.

Authors:  Joel M Gelfand; Howa Yeung
Journal:  J Rheumatol Suppl       Date:  2012-07

Review 2.  Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.

Authors:  J J Wu; A Kavanaugh; M G Lebwohl; R Gniadecki; J F Merola
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-03-14       Impact factor: 9.228

3.  Tobacco smoking was positively associated with metabolic syndrome among patients with psoriasis in Shanghai: A cross-sectional study.

Authors:  Lei Wei; Siting Chen; Yan Qiang; Le Kuai; Mi Zhou; Ying Luo; Yue Luo; Jiankun Song; Xiaoya Fei; Rui Zhang; Ning Yu; Wencheng Jiang; Xin Li; Ruiping Wang; Bin Li
Journal:  Tob Induc Dis       Date:  2022-01-22       Impact factor: 2.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.